Re: Chloroquine (CQ) and Hydroxychloroquine (HQ) Retinal Toxicity Consideration in the Treatment of the Coronavirus Disease 2019 (COVID-19).
Identifieur interne : 000866 ( Main/Exploration ); précédent : 000865; suivant : 000867Re: Chloroquine (CQ) and Hydroxychloroquine (HQ) Retinal Toxicity Consideration in the Treatment of the Coronavirus Disease 2019 (COVID-19).
Auteurs : Paisan Ruamviboonsuk [Thaïlande] ; Timothy Y Y. Lai [République populaire de Chine] ; Andrew Chang [Australie] ; Chi-Chun Lai [Taïwan] ; William F. Mieler [États-Unis] ; Dennis S C. Lam [République populaire de Chine]Source :
- Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) [ 2162-0989 ]
Descripteurs français
- KwdFr :
- MESH :
- traitement médicamenteux : Infections à coronavirus.
- Betacoronavirus, Chloroquine, Coronavirus, Humains, Hydroxychloroquine, Pandémies, Pneumopathie virale.
English descriptors
- KwdEn :
- MESH :
- chemical : Chloroquine, Hydroxychloroquine.
- drug therapy : Coronavirus Infections.
- Betacoronavirus, COVID-19, Coronavirus, Humans, Pandemics, Pneumonia, Viral, SARS-CoV-2.
DOI: 10.1097/APO.0000000000000316
PubMed: 32740072
Affiliations:
- Australie, République populaire de Chine, Taïwan, Thaïlande, États-Unis
- Guangdong, Illinois
- Chicago, Sha Tin, Shenzhen
- Université chinoise de Hong Kong, Université de l'Illinois à Chicago
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Re: Chloroquine (CQ) and Hydroxychloroquine (HQ) Retinal Toxicity Consideration in the Treatment of the Coronavirus Disease 2019 (COVID-19).</title><author><name sortKey="Ruamviboonsuk, Paisan" sort="Ruamviboonsuk, Paisan" uniqKey="Ruamviboonsuk P" first="Paisan" last="Ruamviboonsuk">Paisan Ruamviboonsuk</name><affiliation wicri:level="1"><nlm:affiliation>Department of Ophthalmology, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok, Thailand.</nlm:affiliation><country xml:lang="fr">Thaïlande</country><wicri:regionArea>Department of Ophthalmology, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok</wicri:regionArea><wicri:noRegion>Bangkok</wicri:noRegion></affiliation></author><author><name sortKey="Lai, Timothy Y Y" sort="Lai, Timothy Y Y" uniqKey="Lai T" first="Timothy Y Y" last="Lai">Timothy Y Y. Lai</name><affiliation wicri:level="4"><nlm:affiliation>Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong</wicri:regionArea><orgName type="university">Université chinoise de Hong Kong</orgName><placeName><settlement type="city">Sha Tin</settlement></placeName></affiliation></author><author><name sortKey="Chang, Andrew" sort="Chang, Andrew" uniqKey="Chang A" first="Andrew" last="Chang">Andrew Chang</name><affiliation wicri:level="1"><nlm:affiliation>Sydney Eye Hospital, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Sydney Eye Hospital, Sydney, NSW</wicri:regionArea><wicri:noRegion>NSW</wicri:noRegion></affiliation></author><author><name sortKey="Lai, Chi Chun" sort="Lai, Chi Chun" uniqKey="Lai C" first="Chi-Chun" last="Lai">Chi-Chun Lai</name><affiliation wicri:level="1"><nlm:affiliation>Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan.</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan</wicri:regionArea><wicri:noRegion>Taoyuan</wicri:noRegion></affiliation></author><author><name sortKey="Mieler, William F" sort="Mieler, William F" uniqKey="Mieler W" first="William F" last="Mieler">William F. Mieler</name><affiliation wicri:level="4"><nlm:affiliation>Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois</wicri:regionArea><placeName><region type="state">Illinois</region><settlement type="city">Chicago</settlement></placeName><orgName type="university">Université de l'Illinois à Chicago</orgName></affiliation></author><author><name sortKey="Lam, Dennis S C" sort="Lam, Dennis S C" uniqKey="Lam D" first="Dennis S C" last="Lam">Dennis S C. Lam</name><affiliation wicri:level="3"><nlm:affiliation>International Eye Research Institute of the Chinese University of Hong Kong (Shenzhen), Shenzhen, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>International Eye Research Institute of the Chinese University of Hong Kong (Shenzhen), Shenzhen</wicri:regionArea><placeName><settlement type="city">Shenzhen</settlement><region type="province">Guangdong</region></placeName></affiliation><affiliation wicri:level="1"><nlm:affiliation>C-MER Dennis Lam Eye Centre, C-MER International Eye Care Group Limited, Hong Kong SAR, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>C-MER Dennis Lam Eye Centre, C-MER International Eye Care Group Limited, Hong Kong SAR</wicri:regionArea><wicri:noRegion>Hong Kong SAR</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020 Jul-Aug</date><idno type="RBID">pubmed:32740072</idno><idno type="pmid">32740072</idno><idno type="doi">10.1097/APO.0000000000000316</idno><idno type="wicri:Area/Main/Corpus">001008</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001008</idno><idno type="wicri:Area/Main/Curation">001008</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001008</idno><idno type="wicri:Area/Main/Exploration">001008</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Re: Chloroquine (CQ) and Hydroxychloroquine (HQ) Retinal Toxicity Consideration in the Treatment of the Coronavirus Disease 2019 (COVID-19).</title><author><name sortKey="Ruamviboonsuk, Paisan" sort="Ruamviboonsuk, Paisan" uniqKey="Ruamviboonsuk P" first="Paisan" last="Ruamviboonsuk">Paisan Ruamviboonsuk</name><affiliation wicri:level="1"><nlm:affiliation>Department of Ophthalmology, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok, Thailand.</nlm:affiliation><country xml:lang="fr">Thaïlande</country><wicri:regionArea>Department of Ophthalmology, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok</wicri:regionArea><wicri:noRegion>Bangkok</wicri:noRegion></affiliation></author><author><name sortKey="Lai, Timothy Y Y" sort="Lai, Timothy Y Y" uniqKey="Lai T" first="Timothy Y Y" last="Lai">Timothy Y Y. Lai</name><affiliation wicri:level="4"><nlm:affiliation>Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong</wicri:regionArea><orgName type="university">Université chinoise de Hong Kong</orgName><placeName><settlement type="city">Sha Tin</settlement></placeName></affiliation></author><author><name sortKey="Chang, Andrew" sort="Chang, Andrew" uniqKey="Chang A" first="Andrew" last="Chang">Andrew Chang</name><affiliation wicri:level="1"><nlm:affiliation>Sydney Eye Hospital, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Sydney Eye Hospital, Sydney, NSW</wicri:regionArea><wicri:noRegion>NSW</wicri:noRegion></affiliation></author><author><name sortKey="Lai, Chi Chun" sort="Lai, Chi Chun" uniqKey="Lai C" first="Chi-Chun" last="Lai">Chi-Chun Lai</name><affiliation wicri:level="1"><nlm:affiliation>Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan.</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan</wicri:regionArea><wicri:noRegion>Taoyuan</wicri:noRegion></affiliation></author><author><name sortKey="Mieler, William F" sort="Mieler, William F" uniqKey="Mieler W" first="William F" last="Mieler">William F. Mieler</name><affiliation wicri:level="4"><nlm:affiliation>Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois</wicri:regionArea><placeName><region type="state">Illinois</region><settlement type="city">Chicago</settlement></placeName><orgName type="university">Université de l'Illinois à Chicago</orgName></affiliation></author><author><name sortKey="Lam, Dennis S C" sort="Lam, Dennis S C" uniqKey="Lam D" first="Dennis S C" last="Lam">Dennis S C. Lam</name><affiliation wicri:level="3"><nlm:affiliation>International Eye Research Institute of the Chinese University of Hong Kong (Shenzhen), Shenzhen, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>International Eye Research Institute of the Chinese University of Hong Kong (Shenzhen), Shenzhen</wicri:regionArea><placeName><settlement type="city">Shenzhen</settlement><region type="province">Guangdong</region></placeName></affiliation><affiliation wicri:level="1"><nlm:affiliation>C-MER Dennis Lam Eye Centre, C-MER International Eye Care Group Limited, Hong Kong SAR, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>C-MER Dennis Lam Eye Centre, C-MER International Eye Care Group Limited, Hong Kong SAR</wicri:regionArea><wicri:noRegion>Hong Kong SAR</wicri:noRegion></affiliation></author></analytic><series><title level="j">Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)</title><idno type="eISSN">2162-0989</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (MeSH)</term><term>COVID-19 (MeSH)</term><term>Chloroquine (MeSH)</term><term>Coronavirus (MeSH)</term><term>Coronavirus Infections (drug therapy)</term><term>Humans (MeSH)</term><term>Hydroxychloroquine (MeSH)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (MeSH)</term><term>SARS-CoV-2 (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Betacoronavirus (MeSH)</term><term>Chloroquine (MeSH)</term><term>Coronavirus (MeSH)</term><term>Humains (MeSH)</term><term>Hydroxychloroquine (MeSH)</term><term>Infections à coronavirus (traitement médicamenteux)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Chloroquine</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term><term>COVID-19</term><term>Coronavirus</term><term>Humans</term><term>Pandemics</term><term>Pneumonia, Viral</term><term>SARS-CoV-2</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Betacoronavirus</term><term>Chloroquine</term><term>Coronavirus</term><term>Humains</term><term>Hydroxychloroquine</term><term>Pandémies</term><term>Pneumopathie virale</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">32740072</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2162-0989</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>4</Issue><PubDate><MedlineDate>2020 Jul-Aug</MedlineDate></PubDate></JournalIssue><Title>Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)</Title><ISOAbbreviation>Asia Pac J Ophthalmol (Phila)</ISOAbbreviation></Journal><ArticleTitle>Re: Chloroquine (CQ) and Hydroxychloroquine (HQ) Retinal Toxicity Consideration in the Treatment of the Coronavirus Disease 2019 (COVID-19).</ArticleTitle><Pagination><MedlinePgn>375-376</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/APO.0000000000000316</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ruamviboonsuk</LastName><ForeName>Paisan</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Timothy Y Y</ForeName><Initials>TYY</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sydney Eye Hospital, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Chi-Chun</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mieler</LastName><ForeName>William F</ForeName><Initials>WF</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lam</LastName><ForeName>Dennis S C</ForeName><Initials>DSC</Initials><AffiliationInfo><Affiliation>International Eye Research Institute of the Chinese University of Hong Kong (Shenzhen), Shenzhen, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>C-MER Dennis Lam Eye Centre, C-MER International Eye Care Group Limited, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Asia Pac J Ophthalmol (Phila)</MedlineTA><NlmUniqueID>101583622</NlmUniqueID><ISSNLinking>2162-0989</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>886U3H6UFF</RegistryNumber><NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Asia Pac J Ophthalmol (Phila). 2020 Jul-Aug;9(4):374</RefSource><PMID Version="1">32740070</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017934" MajorTopicYN="Y">Coronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="Y">Hydroxychloroquine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32740072</ArticleId><ArticleId IdType="doi">10.1097/APO.0000000000000316</ArticleId><ArticleId IdType="pii">01599573-202008000-00015</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wiwanitkit V. Chloroquine, Hydroxychloroquine, Retinal Toxicity and COVID-19. Asia-Pacific J Ophthalmol (Phila). 2020;X:XX.</Citation></Reference><Reference><Citation>Ruamviboonsuk P, Lai TYY, Chang A, Lai CC, Mieler WF, Lam DSC. Chloroquine and Hydroxychloroquine Retinal Toxicity Consideration in the Treatment of COVID-19. Asia-Pacific J Ophthalmol (Phila) 2020; 9:85–87.</Citation></Reference><Reference><Citation>Tang W, Cao Z, Han M, et al. Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial. BMJ [Internet] 2020; 369:369.</Citation></Reference><Reference><Citation>Huang M, Tang T, Pang P, et al. Treating COVID-19 with chloroquine. J Mol Cell Biol 2020; 12:322–325.</Citation></Reference><Reference><Citation>Boulware D, Pullen M, Bangdiwala A, et al. A randomized trial of hydroxychloroquine as postexposure prophylaxia for covid-19. N Engl J Med 2020; doi: 10.1056/NEJMoa2016638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2016638</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinton DM. Letter revoking EUA for chloroquine phosphate and hydroxychloroquine sulfate, 6/15/2020 [Internet]. 2020 [cited 2020 Jun 16]. Available from: https://www.fda.gov/media/138945/download.</Citation></Reference><Reference><Citation>Shukla AM, Martinez W, Ly L, Segal MS. A word of caution in the use of hydroxychloroquine in the elderly COVID-19 population. Asia-Pacific J Ophthalmol (Phila). 2020;X:XX.</Citation></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Australie</li><li>République populaire de Chine</li><li>Taïwan</li><li>Thaïlande</li><li>États-Unis</li></country><region><li>Guangdong</li><li>Illinois</li></region><settlement><li>Chicago</li><li>Sha Tin</li><li>Shenzhen</li></settlement><orgName><li>Université chinoise de Hong Kong</li><li>Université de l'Illinois à Chicago</li></orgName></list><tree><country name="Thaïlande"><noRegion><name sortKey="Ruamviboonsuk, Paisan" sort="Ruamviboonsuk, Paisan" uniqKey="Ruamviboonsuk P" first="Paisan" last="Ruamviboonsuk">Paisan Ruamviboonsuk</name></noRegion></country><country name="République populaire de Chine"><noRegion><name sortKey="Lai, Timothy Y Y" sort="Lai, Timothy Y Y" uniqKey="Lai T" first="Timothy Y Y" last="Lai">Timothy Y Y. Lai</name></noRegion><name sortKey="Lam, Dennis S C" sort="Lam, Dennis S C" uniqKey="Lam D" first="Dennis S C" last="Lam">Dennis S C. Lam</name><name sortKey="Lam, Dennis S C" sort="Lam, Dennis S C" uniqKey="Lam D" first="Dennis S C" last="Lam">Dennis S C. Lam</name></country><country name="Australie"><noRegion><name sortKey="Chang, Andrew" sort="Chang, Andrew" uniqKey="Chang A" first="Andrew" last="Chang">Andrew Chang</name></noRegion></country><country name="Taïwan"><noRegion><name sortKey="Lai, Chi Chun" sort="Lai, Chi Chun" uniqKey="Lai C" first="Chi-Chun" last="Lai">Chi-Chun Lai</name></noRegion></country><country name="États-Unis"><region name="Illinois"><name sortKey="Mieler, William F" sort="Mieler, William F" uniqKey="Mieler W" first="William F" last="Mieler">William F. Mieler</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000866 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000866 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32740072
|texte= Re: Chloroquine (CQ) and Hydroxychloroquine (HQ) Retinal Toxicity Consideration in the Treatment of the Coronavirus Disease 2019 (COVID-19).
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32740072" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |